Tower Research Capital LLC (TRC) - BIOTECH ACQUISITION COMPANY ownership

BIOTECH ACQUISITION COMPANY's ticker is BIOT and the CUSIP is G1125A108. A total of 52 filers reported holding BIOTECH ACQUISITION COMPANY in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of BIOTECH ACQUISITION COMPANY
ValueSharesWeighting
Q3 2022$8,0000.0%840
-1.2%
0.00%
Q2 2022$8,000
-20.0%
850
-14.7%
0.00%
Q1 2022$10,000
+400.0%
996
+410.8%
0.00%
Q4 2021$2,000195
+1525.0%
0.00%
Q2 2021$0120.0%0.00%
Q1 2021$0120.00%
Other shareholders
BIOTECH ACQUISITION COMPANY shareholders Q2 2021
NameSharesValueWeighting ↓
RiverPark Advisors, LLC 799,001$7,930,0002.58%
Corbin Capital Partners, L.P. 928,124$9,207,0002.29%
Cohanzick Management, LLC 799,001$7,926,0001.92%
RPO LLC 379,021$3,762,0000.91%
Arena Capital Advisors, LLC- CA 300,000$2,978,0000.90%
Alpha Wave Global, LP 532,570$5,286,0000.62%
MIZUHO SECURITIES USA LLC 444,957$4,383,0000.60%
MMCAP International Inc. SPC 599,321$5,945,0000.47%
GLAZER CAPITAL, LLC 2,285,000$22,667,0000.42%
CVI Holdings, LLC 292,563$2,904,0000.22%
View complete list of BIOTECH ACQUISITION COMPANY shareholders